Frontiers
US$ 22.11
weight loss drugs glp-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for and Obesity GLP-1 receptor agonists – How
Description
Daousi, C., Pinkney, J
Request Sample Report: Global Anti-Obesity Drug Market Key Takeaways According to Coherent Market Insights (CMI), the global anti-obesity drug market size is expected to grow nearly 3.2X by 2032, increasing from USD 25.87 Bn in 2025 to USD 82.55 Bn by 2032
Retatrutide shows comparable glycemic improvements
In early 2026, the FDA also issued warning letters to certain telehealth companies regarding marketing claims about compounded GLP-1 products
